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The RCK-containing MthK channel undergoes two inactivation processes: activation-coupled desensitization and acid-
induced inactivation. The acid inactivation is mediated by the C-terminal RCK domain assembly. Here, we report that
the desensitization gating is governed by a desensitization domain (DD) of the cytoplasmic N-terminal 17 residues.
Deletion of DD completely removes the desensitization, and the process can be fully restored by a synthetic DD
peptide added in trans. Mutagenesis analyses reveal a sequence-specific determinant for desensitization within the
initial hydrophobic segment of DD. Proton nuclear magnetic resonance (
1H NMR) spectroscopy analyses with synthetic
peptides and isolated RCK show interactions between the two terminal domains. Additionally, we show that deletion
of DD does not affect the acid-induced inactivation, indicating that the two inactivation processes are mutually
independent. Our results demonstrate that the short N-terminal DD of MthK functions as a complete moveable module
responsible for the desensitization. Its interaction with the C-terminal RCK domain may play a role in the gating
process.
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Introduction
K
þchannels are found in almost every free-living organism,
with a universally conserved architecture. Typically, a func-
tional K
þ channel is composed of four copies of a pore-
forming subunit of two or six transmembrane (TM) helices
with the amino (N)- and carboxyl (C)-termini usually residing
in the cytoplasm. These cytoplasmic N- or C-terminal
domains can control channel assembly and trafﬁcking, as
well as function as a gatekeeper to regulate the access of K
þto
the ion-conducting pathway [1–5]. A particular form of
control by cytoplasmic domain is exempliﬁed by the RCK [6]
(also known as KTN [7]) domain found in a large number of
prokaryotic K
þ transport systems, including ion channels and
transporters [8], and also in the animal Slo-type K
þ channels
[6]. The crystal structure of the RCK-containing MthK
channel (M107I mutant), from the archaeon Methanobacterium
thermoautotrophicum, provides a relatively simple model,
allowing direct structural, biochemical, and functional
correlations to understand the regulatory roles of the RCK
domain in K
þ channels [9].
Each subunit of MthK is composed of a short cytoplasmic N
terminus of 18 amino acid residues followed by a 2-TM pore-
forming domain. A RCK domain of approximately 220
residues is covalently linked to the C terminus of the second
TM through a linker of 18 residues (Figure 1A, left). On the
basis of the crystal structure of MthK (M107I mutant), four
copies of a separately expressed, soluble RCK domain have
been proposed to interact with the four membrane-tethered
RCK domains in a pairwise manner to form a ‘‘gating ring’’
complex. Binding of Ca
2þ to the domains extends the
diameter of the ring and thus accounts for the activation
gating [9,10]. Later on, it was discovered that besides Ca
2þ,
MthK is also regulated by the pH of the cytoplasmic side such
that the channel becomes completely inactivated at a pH
value below 6.0 [11,12]. This acid inactivation has been
proposed to be modulated by disassociation of a high-order
RCK oligomer into dimers as demonstrated by both
structural and biochemical analyses on the isolated RCK
domain [10–13].
More recently, we discovered that the macroscopic current
of MthK declines spontaneously after Ca
2þ activation on a
timescale of seconds, indicating the channel undergoes a
process called desensitization [11]. This set of experiments
was carried out by directly patch clamping the MthK channels
expressed in enlarged E. coli m e m b r a n e .H o w e v e r ,t h e
puriﬁed MthK channels studied in black lipid membrane
(BLM) has not been observed to undergo desensitization
[12,14,15]. This inconsistent observation raised a question as
to whether this unique desensitization phenomenon observed
in the enlarged E. coli system is an intrinsic molecular
property or an experimental artifact. Besides the difference
in the desensitization phenomenon, another set of incon-
sistent results was also observed from MthK studied by these
two different recording systems. Single-channel analysis of
puriﬁed MthK in the BLM system has shown that the open
probability of MthK is drastically increased when the pH of
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PLoS BIOLOGYthe cytoplasmic side is raised to 8.0 and above, even without
Ca
2þ [12]. A gating ring model has been proposed to explain
this alkaline-activation phenomenon in which alkaline pH
extends the diameter of the octomeric gating ring in the
absence of Ca
2þ to open the channel gate [12]. However, this
alkaline activation was not observed from the MthK studied
in the enlarged E. coli system. Instead, the macroscopic
currents show that MthK continues to require Ca
2þ for
activation followed by subsequent desensitization at alkaline
pH up to 8.5 [11]. Additionally, our biochemical analysis of
the isolated RCK domain at pH values higher than 8.0 has
shown that the domain is predominantly monomeric when
Ca
2þ is absent [11]. This biochemical observation is also
inconsistent with the proposed gating ring model made up by
a stable octomeric RCK assembly [12].
In this report, we ﬁrst demonstrate that the desensitization
phenomenon is indeed intrinsic to the MthK channel, and the
gating process is controlled by the cytoplasmic N-terminal 17
residues. By mutational and
1H NMR analyses, we further
demonstrate that the desensitization gating mechanism may
involve interactions between the N-terminal desensitization
domain (DD) and C-terminal RCK domain. Additionally, we
show that the desensitization and acid-inactivation gatings
are controlled by distinct parts of the channel, and the
processes are mutually independent. Finally, we demonstrate
that MthK requires Ca
2þ for activation in all ranges of pH as
high as pH 9.0, the pH at which the isolated RCK domain
undergoes a monomer-to-oligomer conversion by the pres-
ence of Ca
2þ.
Results
Desensitization of MthK Involves Its Cytoplasmic N
Terminus
The MthK channels studied in this work were expressed in
giant E. coli spheroplasts. Patch clamping with inside-out
membrane patches was coupled with a rapid perfusion system
to study the time-dependent channel kinetics in a timescale
of milliseconds. Patches containing approximately 100–600
active wild-type MthK channels were usually observed when
the giant spheroplasts were prepared with IPTG (isopropyl b-
D-1-thiogalactopyranoside) treatment to promote the expres-
sion. This has allowed us to study the macroscopic behavior of
the channel [11]. MthK has been shown to be activated by
millimolar concentrations of Ca
2þ with a half-effective
concentration around 8.5 mM at pH 7.5 and  50 mV [11].
When activated by 20 mM or an excessive amount (100 mM)
of Ca
2þ, the wild-type MthK current shows spontaneous decay
within seconds, indicating that the channels undergo desen-
sitization (Figure 1A, left and middle traces, respectively).
Single-channel recording from giant spheroplasts without
IPTG treatment reveals that the open probability of wild-type
MthK decreases during the extended Ca
2þ perfusion (Figure
1A, right trace).
In an attempt to test the functionality of MthK after being
fused with the Mistic protein of Bacillus subtilis [16] to its N
terminus (see Materials and Methods), we found that this
Mistic-MthK chimera does not desensitize to Ca
2þat either 20
or 100 mM (Figure 1B, left and middle traces, respectively),
though the number of active channels in an excised patch is
drastically reduced. To test whether the disappearance of
MthK desensitization is speciﬁc to the N-terminally fused
protein, the Mistic protein was replaced with a 33-residue
peptide containing a nona-histidine tag (Materials and
Methods). Interestingly, the resulting 9xHis-MthK chimera
also does not undergo desensitization (Figure 1C). These
observations led us to hypothesize that the N terminus of
MthK may be involved in the desensitization process in the
wild-type channel.
To test this hypothesis, the entire cytoplasmic N terminus
of MthK, from Val2 to Lys17, was deleted for examination.
The macroscopic current of this D2–17 MthK channel shows
rapid Ca
2þ activation as the wild-type channel does, but the
current does not decline during sustained Ca
2þ perfusion at
either 20 or 100 mM (Figure 1D, left and middle traces,
respectively). The channel open probability also does not
decrease during the extended Ca
2þ perfusion (Figure 1D,
right trace), indicating that the desensitization process is
completely abolished in the D2–17 MthK. Therefore, we
conclude that the short N terminus of MthK is required for
desensitization.
Synthetic N-Terminal Peptide Restores the Desensitization
to D2–17 MthK In Trans
The deletion experiment described above is reminiscent of
the ‘‘ball’’ for the N-type inactivation in the mammalian
Shaker K
þ channels [17]. To test the idea, an artiﬁcial aa1–17
peptide, corresponding to the ﬁrst 17 residues of MthK, was
synthesized and added to the perfusate to test its effect on the
D2–17 MthK. To this end, the D2–17 MthK channels in an
excised inside-out patch were ﬁrst activated by 20 mM Ca
2þ
(Ca20 solution) for 20 s (Figure 2A). The synthetic peptide was
then added to the cytoplasmic side by stepping the perfusate
to the same Ca
2þ solution with an additional 10 lM aa1–17
peptide (Figure 2A, red bar). Surprisingly, the addition of the
aa1–17 peptide drastically reduces the open probability of
D2–17 MthK at the single-channel level (Figure 2A, upper
trace), and causes the macroscopic current to decay down to
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Desensitization Mechanism of MthK
Author Summary
Nerve cells use ion channels, pores in the cell membrane, to send
messages in the form of electrical signals between cells. Most ion
channels have evolved several elaborate mechanisms that allow the
channels to close quickly after opening to prevent wasteful leakage
of the electrochemical potential—the currency of neuron commu-
nication—across the cell membrane. The process is known as
inactivation or desensitization. Previous study on the model RCK-
containing MthK K
þ channel in the enlarged Escherichia coli
membrane has shown that this archaeon channel also undergoes
desensitization. Using the same method, we demonstrate that the
desensitization is indeed an intrinsic molecular property of the MthK
protein. We show that a specific region of MthK, the short N
terminus of the protein, functions as a structurally independent
domain and is entirely responsible for the desensitization gating
process. Moreover, we show that this N-terminal domain interacts
with the C-terminal RCK domain as part of the desensitization
mechanism. This unique desensitization mechanism, by interaction
between the two cytoplasmic termini, is distinct from those
traditional mechanisms known as N- and C-type inactivation found
in many voltage-gated Na
þand K
þchannels or as the desensitization
observed in the glutamate receptors. Since the KTN/RCK domain is
found in a large number of prokaryotic K
þ channels and trans-
porters, this unique mechanism may be common to these transport
systems for regulating the K
þ flux through the cell membrane.zero in about 30 s (Figure 2A, bottom trace). These results
show that the synthetic aa1–17 peptide is able to inhibit the
activity of D2–17 MthK in a way similar to the desensitization
process of the wild-type channel. Note that to distinguish this
inhibitory process by the synthetic aa1–17 peptide versus the
desensitization process by the natural N terminal DD in wild-
type channel, we will refer to the inhibitory process as
peptide desensitization.
The dose response of the peptide desensitization was
examined between 3 to 1,000 lM. The time courses of the
peptide desensitization can be ﬁtted with single exponentials
(Figure 2B). We found that at 10 lM, the rate of peptide
desensitization (s ¼ 4.23 6 1.34 s; Figure 2B, brown trace) is
close to that of the wild-type MthK desensitization (5.7 6 0.6
s; Figure 1A), which can be regarded as the virtually local
concentration of the native DD in wild-type MthK. At
concentrations above 100 lM, the time constant reaches its
limit of around 0.3–0.5 s (Figure 2B, green and blue traces).
Figure 1. Representative Macro- and Microscopic Traces of Different MthK Constructs Expressed in E. coli Membrane
Excised inside-out patches were held at 50 mV. Macroscopic traces (left and middle, from same patches) were recorded from cells with IPTG treatment.
Single-channel traces (right) were recorded from cells without IPTG treatment. Channels were activated by stepping the perfusate from EGTA to either
Ca20 or Ca100 solution at pH 7.5 using a rapid perfusion system.
(A) Traces of wild-type MthK. The macroscopic Ca
2þ-activated current decays in a few seconds after being activated by 20 (left trace) or 100 (middle
trace) mM Ca
2þ. The single-exponential time constants for the decays are 5.7 6 0.6 s and 4.2 6 1.2 s (n¼6), respectively. Right trace, a single-channel
trace shows that the channel’s open probability decreases during the extended 20 mM Ca
2þ perfusion.
(B) A Mistic protein [16] was fused to the N-terminus of MthK to create the Mistic-MthK chimera (Materials and Methods). The traces show that the
chimeric channels remain active during the prolonged Ca
2þ perfusion.
(C) Fusing a nona-histidine-containing peptide (Materials and Method) to the N-terminus of MthK also results in chimeric channels that remain active
during the sustained Ca
2þ perfusion.
(D) The entire cytoplasmic N-terminus of MthK was deleted to create the D2–17 MthK. Macroscopic traces of the deletional mutant shows that the
current does not decay in either 20 or 100 mM Ca
2þ. A single-channel trace with two active channels shows that the open probability does not decrease
in the Ca
2þ solution. Dashed lines indicate zoom in of a segment of the trace. All traces represent more than five independent patches.
doi:10.1371/journal.pbio.0060223.g001
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Desensitization Mechanism of MthKThe inhibition of the channel activity by the synthetic
peptide is not permanent. The peptide-desensitized channels
can be slowly, but readily, returned back to the open state
after removing the peptide from the perfusate with a time
constant of approximately 135 s (Figure 2C, red lines).
The rate of recovery back to the closed state was
determined by simultaneously removing the Ca
2þand peptide
using a two-activation protocol. As shown in Figure 2D, the
D2–17 MthK channels in an excised patch were ﬁrst activated
by 20 mM Ca
2þ for 20 s to determine the maximal activatable
current before adding 10 lM aa1–17 peptide to fully
desensitize the channels. The peptide and Ca
2þ were then
withdrawn simultaneously for various lengths of time (Figure
2D, red bar) to allow the peptide-desensitized channels to
recover back to the closed state. The number of channels that
have recovered to the closed state was determined by a
second Ca
2þ activation (Figure 2D, arrow). By comparing the
amplitudes of the two Ca
2þ-activated peaks, we found that the
t i m ec o u r s eo ft h er e c o v e r yh a sat i m ec o n s t a n to f
approximately 0.59 s (Figure 2D, bottom panel), which is
about 200-fold faster than that of the recovery of wild-type
MthK from the desensitized state back to the closed state (s
;110 s [11]). Since the DD in wild-type MthK is membrane
tethered at the N terminus, the much faster recovery of the
peptide-desensitized D2–17 MthK to the closed state can be
partly explained by an entropic gain of the freely diffusing
aa1–17 peptide.
The Initial Hydrophobic Segment of the N Terminus Is
Important for Desensitization
The results thus far demonstrate that the cytoplasmic N-
terminal 17 residues of MthK alone form a complete movable
module, which can be deleted and added in trans to abolish
or reconstitute the desensitization phenomenon, respectively.
Figure 2. Effects of Synthetic N-Terminal 17-Residue Peptide on the D2–17 MthK Channels
(A) A single-channel trace (top) shows that the channel open probability decreases when 10 lM synthetic peptide (aa1–17) was added to the perfusate
(red bar). Bottom, a macroscopic trace shows that the Ca
2þ-activated current decays during the aa1–17 perfusion. The results indicate that the synthetic
aa1–17 peptide is able to restore the desensitization phenomenon in trans.
(B) Overlapped traces of the peptide-induced desensitization at different peptide concentrations. Smooth curves indicate single exponential fitting.
Gray trace is 3 lM, which has a time constant of 14.75 6 2.77 s; brown, 10 lM, 4.23 6 1.34 s; red, 30 lM, 1.47 6 0.34 s; green, 100 lM, 0.51 6 0.13 s;
blue, 1,000 lM, 0.37 6 0.04 s (mean 6 SD, n ¼ 9–15).
(C) A recording episode to determine the rate of recovery of the peptide desensitized channels back to the open state (red bar). The smooth curve
shows single exponential fitting. The time constant is 135 6 20 s (mean 6 SD, n ¼ 8).
(D) Rate of recovery of the peptide desensitized channels back to the closed state (red bar). The time constant is 0.59 s (bottom panel, SDs are shown, n¼5).
doi:10.1371/journal.pbio.0060223.g002
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Desensitization Mechanism of MthKWe then refer to it as the desensitization domain, DD (Figure
3A). In the original X-ray structure, the N-terminal 18
residues of MthK were not resolved in the structural model
(Protein Data Bank [PDB] code 1LNQ [9]). Therefore, to
deﬁne the residues or regions within DD that are important
for the desensitization process, we performed mutational
analyses within the DD by deletion and point mutation. In a
series of sequential deletion, we found that the deletions
within the ﬁrst 11 residues often result in mutant channels
with signiﬁcantly altered gating properties. For examples, the
deletion of two residues, from Val2 to Leu3 (D2–3), increases
the rate of desensitization (s¼995 6 82 ms, n¼5; Figure 3B),
whereas the deletion of four residues, from Val2 to Ile5 (D2–
5), results in an activation spike followed by a further slow
current decay (Figure 3C). Deletion of six residues, from Val2
to Ile7 (D2–7), results in partial desensitization (Figure 3D),
and deletion of ten residues (D2–11) completely removes the
desensitization process (Figure 3E).
The drastic effects of the N-terminal deletions on the
gating proﬁle led us to hypothesize that the initial hydro-
phobic segment, containing Met1, Val2, Leu3, Val4, and Ile5,
may be important for desensitization. These hydrophobic
residues were then replaced individually by an aspartate (D)
reside to test the idea. Interestingly, introducing the charged
residue at the second (V2D) or third (L3D) position removes
the desensitization process almost completely (Figure 3F and
3G, respectively). At the fourth (V4D) and ﬁfth (I5D)
positions, the charged residue also signiﬁcantly alters the
gating property. (Figure 3H and 3I, respectively). The effect of
the charged residue at the initial hydrophobic segment was
also tested with a synthetic N-terminal peptide, containing a
L3D mutation (aa1–17(L3D) peptide). When tested at 100 lM,
the mutant aa1–17(L3D) peptide is much less effective to
inhibit the D2–17 MthK activity (Figure 3J, left trace) than the
wild-type aa1–17 peptide treated subsequently on the same
patch (Figure 3J, right).
Since the disruption of the initial hydrophobicity has a
profound effect on the desensitization process, we then went
on to test whether this hydrophobic segment alone is able to
inhibit the D2–17 MthK activity. Interestingly, this hydro-
phobic segment (aa1–6 peptide), when applied at 100 lM, has
almost no inhibitory effect on the D2–17 MthK channels
(Figure 3K, left trace). However, the longer aa1–11 peptide is
able to inhibit the current as effectively (Figure 3K, right) as
the aa1–17 peptide does (Figure 3J, right), but with a bit
higher residual activity at the steady state.
The Desensitization Domain Interacts with Isolated RCK
Domain
If the N-terminal DD of MthK is the primary structural
determinant of the desensitization process, how does it
render the channel into the desensitized state? As revealed
in the crystal structure, the closest distance between Pro19
(the N terminus of TM1) and the membrane-facing side of the
RCK domain is about 8 A ˚ (PDB code 1LNQ). The physical
proximity of the N- and C-terminal domains suggests that the
DD may interact with RCK domain. To probe any possible
interactions between these two domains in a sequence-
speciﬁc manner, we used
1H NMR spectroscopy to analyze
the behavior of synthetic DD peptides in response to the
presence of isolated RCK domain in pH 7.5 solution. To this
end, the aa1–17, aa1–17(L3D), aa1–11, and aa1–6 peptides,
Figure 3. Mutational Analyses at the Cytoplasmic N-Terminus of MthK.
Activation was done by stepping the perfusate from EGTA to Ca20
solutions at pH 7.5. (A) Left, amino acid sequence of the N-terminal
desensitization domain (DD) of MthK. Hydrophobic residues are shown
in gray. Right, a typical macroscopic trace of wild-type MthK.
(B–E) Traces of sequential N-terminal deletion mutants show that
truncations of DD result in significantly altered channel gating proper-
ties.
(F–I) Traces of single-point mutations (asterisks) at the initial hydro-
phobic residues of the DD show that introducing a charged aspartate
residue to disrupt the initial hydrophobicity drastically alters the gating
profile.
(J) Traces recorded from the same patch show the effects of 100 lM aa1–
17(L3D) peptide (left trace) and aa1–17 peptide (right trace) on open D2–
17 MthK channels.
(K) Traces from the same patch, containing D2–17 MthK channels, show
the effects of the aa1–6 (left trace) and aa1–11 (right trace) peptides.
Typical traces are shown, representing four to six independent patches
for (B–K).
doi:10.1371/journal.pbio.0060223.g003
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Desensitization Mechanism of MthKwhich have been functionally tested on the D2–17 MthK
channel above, were analyzed individually by titrating the
isolated RCK protein at various molar ratios (Figure 4). As
shown in the bottom 1:0 traces of Figure 4A, 4B, and 4C, the
aa1–17, aa1–11, and aa1–17(L3D) peptides give three distinct
narrow peaks, corresponding to the C
e1H (7.73 ppm) and
C
d2H (6.96...6.98 ppm) ring protons of the His11, and to the
C
eH3–protons (2.10 ppm) of the Met1. With the aa1–6
peptide, the peak of C
eH3 protons of the Met1 was also
observed at the same position (Figure 4D, bottom-right trace)
together with two other peaks from the protons of the C-
terminal amide group (Figure 4D, asterisks). These well-
resolved, narrow peaks indicate that the peptides are in a
rapidly tumbling state, corresponding to an unbounded form
in the solution. If strong physical interactions between the
peptide and the slowly rotating RCK protein occur, dis-
appearance or displacement of these characteristic peaks will
be observed. This is due to signiﬁcant line broadening or
shift, caused by a much shorter t2 relaxation time of the RCK
protein or changes in these protons’ local environment,
respectively [18].
During the titration of RCK protein with peptides,
signiﬁcant differences in the behaviors of the four peptides
were observed. For the aa1–17 peptide, the three character-
istic peaks disappear at [aa1–17]:[RCK] ratios of 1:5 and 1:2
(Figure 4A, second and third rows, respectively). At 1:1 ratio,
broadened and lowered intensity peaks of His11 ring protons
were detected (Figure 4A, fourth row, left trace), but not the
peak from Met1 (right trace). The similar disappearance of
the peaks was also observed from the aa1–11 peptide (Figure
4B). Conversely, for the aa1–17(L3D) peptide, all three
characteristic peaks were clearly detectable at the same
Figure 4. The 700-MHz
1H NMR Spectra of Isolated RCK Domain Titration by Synthetic Peptides
The regions of 8.7...6.4 ppm and 2.4...1.9 ppm of the spectra are shown. The spectrum of the RCK domain without peptide is shown in the top rows;
spectra of free peptides are shown in the bottom rows. Characteristic peaks are traced with the dotted lines.
(A and B) Isolated RCK protein titrated with aa1–17 and aa1–11 peptides. The three characteristic peaks of the peptides disappeared when mixed with
the RCK protein.
(C and D) Isolated RCK protein titrated with the mutant aa1–17(L3D) and aa1–6 peptides. The characteristic peptide peaks are clearly detected in the
peptide-RCK mixtures (arrowheads). Asterisks indicate peaks from the protons of the C-terminal amide group.
doi:10.1371/journal.pbio.0060223.g004
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Desensitization Mechanism of MthKpositions, starting from 1:5 to 1:1 ratios (Figure 4B, arrow
heads). For the aa1–6 peptide, the peak from Met1 was also
detectable at the three titration ratios (Figure 4D, arrow
heads). The disappearance of the characteristic peaks of the
aa1–17 and aa1–11 peptides, but not those of the aa1–17(L3D)
and aa1–6 ones, indicates that the aa1–17 and aa1–11
peptides have stronger interaction with the isolated RCK
protein than the aa1–17(L3D) and aa1–6 peptides do in a
residue-speciﬁc manner.
Closed D2–17 MthK Can Be Desensitized by a High
Concentration of aa1–17 Peptide
In Figure 2, we showed that applying the DD peptide while
the D2–17 MthK channels are in the open state can inhibit the
channel activity. The decrease in the macroscopic current
may be due to either open pore blockage, similar to the ‘‘ball-
and-chain’’ model of the Shaker K
þ channels, or an allosteric
blockage, possibly through an interaction between RCK and
DD. To delineate between these two possible mechanisms, we
tested the effect of the DD peptide on the closed channels by
adding the peptide to the EGTA solution. To this end, the
D2–17 MthK channels in an excised patch were ﬁrst activated
twice with a 5-s interval in-between to be certain that the 5-s
EGTA perfusion, after the ﬁrst Ca
2þ activation, is able to
completely return the channels to the closed state (Figure 5,
left trace). Ten or 100 lM synthetic DD peptide in EGTA
solution was then added to the perfusate, after the 5-s EGTA
perfusion, for 0.5 s prior to the second Ca
2þactivation (Figure
5, left and right arrows, respectively). Since the channels have
fully returned to the closed state during the 5-s EGTA
perfusion, applying DD peptide afterward allows examination
of the peptide effect on channels that are in the closed state.
Interestingly, by comparing the amplitude of the two Ca
2þ-
activation peaks, we found that the perfusion of 100 lMD D
peptide is able to inhibit about 40% (43.3 6 13.9%, n ¼ 5) of
the closed channels (Figure 5, right trace), whereas 10 lMD D
peptide has little effect on the closed channel (5.1 6 3.6%
inhibited, n ¼ 5; Figure 5, middle trace). Since no channel
opening was observed during the 0.5 s of peptide perfusion,
these results demonstrate that the synthetic aa1–17 peptide,
when applied at high concentration, is able to shift the
equilibrium of the D2–17 MthK channel directly from the
closed to the peptide-desensitized state.
pH Effects on Acid-Inactivation Gating and Activation
Gating
Our previous analysis has shown that the rate of macro-
scopic decay of the wild-type MthK current depends on the
pH of the Ca
2þ solution (Figure 6A [11]). Since the
desensitization process can now be completely removed by
deleting the DD, we also examined the pH response of the
D2–17 MthK to see whether there is a correlation between the
desensitization and the acid-inactivation processes. As shown
in Figure 6B, at pH above 7.5, the macroscopic currents of
D2–17 MthK show little decline (Figure 6B, left two traces),
whereas dramatic decay in the macroscopic currents starts
when the pH is shifted to 7.0 or lower (Figure 6B, right 3
traces), indicating that the pH inactivation is insigniﬁcant at
pH above 8.5 and maximized at pH below 6.5. This result is
similar to that determined from wild-type MthK [11],
suggesting that the deletion of DD has little effect on the
acid-inactivation gating process, and the two inactivation
processes have no synergy effect.
Single-channel analysis on puriﬁed MthK in BLM has
shown that the channel open probability is drastically
increased when the pH of the cytoplasmic side is above 8.0,
even in the absence of Ca
2þ [12]. We also examined this
alkaline pH effect on both wild-type and D2–17 MthK in E.
coli membrane. Contrary to the BLM data, our analyses show
that the activation of either wild-type or D2–17 MthK at pH
values as high as 9.0 still requires the presence of at least
submillimolar concentration of Ca
2þ (Figure 7A, upper and
lower traces, respectively). When examined at pH 9.0, the
oligomeric state of the isolated RCK domain is predominately
monomeric in EGTA solution and multimeric in Ca
2þ
solutions (Figure 7B), much the same as what we previously
Figure 5. Behavior of D2–17 MthK upon the Perfusion of Synthetic aa1–17 Peptide to the Cytoplasmic Side of the Patch When the Channels Are in the
Closed State
Left, trace of two Ca
2þ-activation peaks shows the channels in the excised patch, after being activated by the first Ca20 perfusion, are able to return fully
to the closed state during the 5-s EGTA perfusion. Dashed lines indicate the average amplitude of the peaks.
Middle and right, traces show the effects of adding 10 and 100 lM DD peptide (arrows) to the closed channels, respectively. Traces are from a single
patch, representing five independent patches.
doi:10.1371/journal.pbio.0060223.g005
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Desensitization Mechanism of MthKobserved at pH 8.5 [11]. The gating behavior of MthK at
extreme alkaline pH values examined in E. coli membrane
correlates well with the solution behavior of the isolated RCK
domain, which supports the idea that the activation gating of
MthK is controlled by oligomeric RCK conversion [11].
Discussion
Functional Analyses of MthK
Previous studies of MthK were carried out by purifying the
channel proteins and reconstituting them in BLM [12,14,15].
Although this method ensures that the activities observed
originate from the pure proteins, the BLM system cannot
readily resolve the rapid ligand-gating kinetics because of the
time required for chamber perfusion. Therefore, the gating
properties previously studied in BLM may not reﬂect those of
activation gating [19]. Biochemical analyses of the isolated
RCK domain of MthK have shown that the domain is able to
form various oligomeric states, including 1-mer, 2-mer, 4-
mer, 6-mer, and 8-mer, depending on the pH and Ca
2þ
[10,11,13]. In this study, we propose that the synthetic N-
terminal DD induces desensitization by interacting with the
RCK domain (below). Based on these observations, it is
possible that the separately expressed free RCK protein,
which has been shown to be copuriﬁed with the full-length
MthK [9,14], can bind to either the N-terminal DD or the
membrane-tethered C-terminal RCK domain. Although the
native form of the DD-RCK or RCK-RCK interaction is
unclear, these interactions could possibly be altered during
the puriﬁcation and reconstitution processes. For instance,
the crystal structure of the MthK (M107I mutant) shows that
the two channels interact with each other through the
member-tethered RCK domains after being extracted and
puriﬁed [9]. Therefore, whether the conformation of the
reconstituted MthK in the BLM system remains the same as
those in the cell membrane needs to be established.
To avoid possible alternations in the natural conformation,
we have expressed MthK in the membrane of giant E. coli
spheroplasts for direct patch clamp [11]. The desensitization
property was discovered when the excised patches were
bathed in a stream of perfusate that can be switched within
tens of milliseconds [11]. The E. coli patch-clamp method
forgoes the simplicity of BLM reconstitution but provide a
natural setting to examine the channel without altering the
native RCK assembly. However, a logical possibility exists that
a protein native to E. coli may interact with the MthK protein
from the cytoplasm, causing it to desensitize. In this study, we
addressed this question by showing that the desensitization
phenomenon of MthK can be removed by deleting its N-
terminal DD and can be re-established by a synthetic DD
peptide, and its shorter variants, added in trans. These results
are consistent with the conclusion that the desensitization
p r o c e s si sa ni n t r i n s i cm o l e cular property. To further
characterize how the DD and RCK domains modulate the
gating of MthK, reconstituting puriﬁed channels into an
artiﬁcial liposome for patch clamp may provide a more
advanced system to circumvent possible heterologous inter-
actions in giant E. coli system, as well as to resolve rapid
kinetics [20–22].
Mechanism of MthK Desensitization
Our initial observations had reminisced the works of the N-
type ball-and-chain inactivation model in the voltage-gated
Shaker K
þ (Kv) channels [17]. In Shaker-type Kv channels, the
N-type inactivation was restored to inactivation peptide (IP)-
truncated channels by a synthetic IP segment of approx-
Figure 6. Behavior of Wild-Type and D2–17 MthK in Response to the pH of the Cytoplasmic Side
The channels were activated by stepping the perfusate from EGTA (pH 8.5) to Ca20 (pH 8.5) solutions for 1 s, and then to Ca20 solution at different pH
values for 90 s.
(A) Traces of wild-type MthK currents recorded from the same patch, representing five independent patches. After each activation episode, the patch
was perfused with EGTA (pH 8.5) solution for more than 8 min for the channels to recover back to the closed state.
(B) Traces of D2–17 MthK show that the currents were inactivated by neutral to slightly acidic pH. Ensemble currents of three independent patches are
shown.
doi:10.1371/journal.pbio.0060223.g006
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Desensitization Mechanism of MthKimately 20 amino acids located at the N-terminal end of the
Shaker channel subunits [23,24]. The current model for Shaker
inactivation is that the IP ball, as an unfolded chain, reaches
the intracellular cavity of the pore through the lateral
opening between T1 and the TM domain of the channel. In
this model, a single IP acts like a quaternary ammonium
channel blocker and can access and physically occlude the
central ion pathway of an open channel [25–33].
In MthK, the DD, which is about the size of the IP ball, is
directly attached to the MthK channel body without a ‘‘chain’’
as seen in the Shaker channels. Therefore, does the DD
desensitize MthK by reaching the intracellular cavity to block
the pore, or by interacting with other parts of the channel to
cause allosteric blockage? Our analyses using the synthetic
DD peptide showed that the rate of peptide desensitization
varies between subseconds to tens of seconds, depending on
Figure 7. Behavior of MthK and the Isolated RCK Domain in Response to Ca
2þ at pH 9.0
(A) Representative macroscopic traces of wild-type MthK (upper trace) and D2–17 MthK (bottom trace) show that stepping the perfusate from EGTA (pH
7.5) to EGTA (pH 9.0) then to Ca0 (pH9.0) solution does not activate the channels. Activation of MthK at pH 9.0 still requires sub- to millimolar
concentrations of Ca
2þ (last 2 steppings). Digitized at 2.5 kHz and filtered at 1 kHz. Ca0, Ca0.5, and Ca20 solutions contain (in mM) 10 Tris-HCl (pH 9.0),
150 KCl, 500 sucrose, and 0, 0.5, or 20 CaCl2, respectively. (n ¼ 3 patches).
(B) Oligomeric states of the isolated RCK domain at pH 9.0 in the presence of EGTA or Ca
2þ, determined by size-exclusion chromatography (smooth
lines) and static light scattering (dots). The retention volumes for each of the corresponding peaks are 11.9 ml (20 mM Ca
2þ), 12.6 ml (0.5 mM Ca
2þ), and
15.8 ml (5 mM EGTA). Molar masses for each of the corresponding peaks are 170 6 10 kDa (20 mM Ca
2þ), 106 6 4 kDa (0.5 mM Ca
2þ), and 26.5 6 2.3
kDa (5 mM EGTA).
doi:10.1371/journal.pbio.0060223.g007
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Desensitization Mechanism of MthKthe peptide concentration. And the recovery of the peptide-
desensitized channel depends on Ca
2þ, such that the recovery
is much faster when Ca
2þ is removed than when present. This
kinetic behavior of DD peptide blockage is quite different
from that of the TBA (tetrabutylammonium) pore blockage.
When examined between 0.01 and 10 mM, the rates of TBA
blockage and recovery on open D2–17 MthK channels are
both around tens of milliseconds (unpublished data). Since
the quaternary ammonium compound is known to block K
þ
channels by directly plugging into the intracellular cavity of
the pore [31], the much slower rates of DD peptide blockage
suggest that the blocking mechanism may not simply be the
same as the TBA pore blocker. Consistent with this
conclusion is the observations that the shorter aa1–6 peptide
has almost no blocking effect, and the aa1–11 peptide is not
able to fully block the D2–17 MthK channels as the aa1–17
peptide does at steady state. These results indicate that the
initial hydrophobic segment of the DD alone is not able to act
like the quaternary ammonium pore blocker. Instead, the
subsequent residues, from Ile7 to Lys17, also play a role to
complete the gating modulation. Furthermore, in Figure 5,
we showed that perfusion of DD peptide at substantially high
concentration to the cytoplasmic side of D2–17 MthK can
desensitize the channels without opening. This result in-
dicates that the binding site for the DD peptide is accessible
in the closed channel, and the DD blockage is rather
allosteric.
In the
1H NMR analyses, we demonstrated that the aa1–17
and aa1–11 peptides, but not the mutant aa1–17(L3D) or aa1–
6 peptide, directly interact with the isolated RCK domain.
These binding results correlate well with the functional
analyses in which the aa1–17 and aa1–11 peptides, but not the
mutant aa1–17(L3D) or aa1–6 peptide, are able to inhibit the
K
þ current. This direct correlation between protein binding
and channel blockage suggests that the physical interaction of
the synthetic DD peptide to the RCK domain is required to
cause the peptide-desensitization. Although the results of
peptide desensitization should be interpreted with caution to
surmise the native desensitization mechanism, it is plausible
that the N-terminal DD in the wild-type MthK interacts with
the C-terminal RCK domain in the similar way to render the
channel into the desensitized state after Ca
2þ activation.
Further functional characterizations of the natural and
peptide desensitization are required to compare the differ-
ences and similarities of these two mechanisms. Note that this
set of experiments highlights that an interaction between the
N-terminal DD and C-terminal RCK domain may be
responsible for the desensitization gating process; however,
it does not exclude additional interaction of DD with other
parts of the channel, including the transmembrane pore
region. Given that the structure of DD is not resolved in the
crystal structure of MthK (M107I), further elucidating the
detailed DD-RCK interaction of the entire MthK structure at
atomic scale may help understanding how the interactions
participate in the gating process.
Results in this report together with previous studies of
others provide a converging view that the gating mechanisms
of activation, of activation-coupled desensitization and of the
acid-induced inactivation are largely mediated by conforma-
tional changes in the RCK domain, namely the desensitization
by DD and the acid inactivation by RCK disassembly into
dimers at acidic pH [11–13]. For activation gating, however, it
remains to be better understood how Ca
2þ-triggered con-
formational change of the RCK domains results in channel
opening. In conclusion, these dynamic Ca
2þ-, pH-, and DD-
dependent conformational changes of RCK domain underlie
the mechanistic basis of MthK gating.
Materials and Methods
Molecular biology. The gene of wild-type MthK was cloned into the
pB11d vector between the NcoI and XhoI sites behind a LacUV5
promoter. The N-terminal mutants were created by designing the 59
PCR mutant primer with a restriction cutting site compatible with
NcoI for ligating into the vector. All the mutations were conﬁrmed by
DNA sequencing. The Mistic-MthK and 9xHis-MthK chimeras were
made by cloning the MthK ORF into a Gateway-adapted Mistic-
containing pMIS4 and a Gateway-adapted pHis9 vector [11],
respectively. The amino acid sequences before the Methionine1 of
MthK in the 9xHis-MthK chimera is MKHHHHHHHHHGGLEST-
SLYKKAGSLVPRGSGS (33 residues). Mistic is a ‘‘membrane-inte-
grating’’ protein from B. subtilis. It was originally discovered for its
ability to increase the expression of eukaryotic membrane proteins in
E. coli when it is fused to the N terminus [16,34]. We originally made
the Mistic-MthK chimera to study potential effects of Mistic on the
functionality of its MthK cargo.
Electrophysiology. The preparation of giant E. coli spheroplasts
and the patch-clamp recordings were performed following the
protocol previously described [11,35] with minor modiﬁcations. In
brief, the plasmids containing wild-type or mutant MthK were
transformed in FRAG1 (Dkch) strain [36] for expression. The Gateway-
adapted plasmids, containing the chimeras, were transformed in the
BL21Star(DE3) strain (Invitrogen). A fresh single colony was
inoculated in 5 ml of modiﬁed LB medium (10 g/l tryptone, 5 g/l
yeast extract, and 5 g/l NaCl), supplemented with an antibiotic to
maintain the plasmid. The culture was incubated at 250 rpm, 37 8C,
until the optical density at 600 nm (OD600) reaches approximately 0.3,
and then diluted 10-fold into a prewarmed modiﬁed LB medium,
supplemented with the antibiotic and 60 lg/ml cephalexin to block
cell ﬁssion. For macroscopic recordings, 0.5 mM IPTG was added to
the culture after 2 h of incubation to promote the gene expression
for 1.5 h. For single-channel recordings, the culture was incubated for
4 h at 250 rpm, 37 8C without adding IPTG. The expression from the
basal leakage of the LacUV5 and T7 promoters allows us to obtain
patches containing fewer than ten channels (Figure 1, right traces).
The ﬁlamentous cells were harvested in a 1.5-ml Eppendorf tube by
centrifugation and then resuspended with 500 ll of 0.8 M sucrose.
Thirty microliters of 1 M Tris-HCl (pH 8.0), 24 ll of 0.5 mg/ml
lysozyme, 6 ll of 5 mg/ml DNase, and 6 ll of 125 mM EDTA-NaOH
(pH 8.0) were added in sequence and mixed immediately in-between
by inverting the tube a few times. After approximately 8 min of
incubation at room temperature, 100 ll of Stop Solution (10 mM
Tris-HCl [pH 8.0], 0.7 M sucrose, 20 mM MgCl2) was added to
terminate the digestion. The spheroplasts were directly used for
patch clamp or frozen at  80 8C for later use.
For all the patch-clamp recordings, the pipettes were ﬁlled with the
Ca20 solution, containing (in mM) 10 Hepes-Tris (pH7.5), 500 sucrose,
150 KCl, and 20 CaCl2. The EGTA solution contains 10 Hepes-Tris
(pH7.5), 500 sucrose, 150 KCl, 20 MgCl2, and 5 EGTA. The bath was
ﬁlled with either the Ca20 or EGTA solution together with the giant
spheroplasts for gigohm seal formation. (The 500 mM sucrose
provides osmotic protection and prevents the giant spheroplast from
bursting during the seal formation. For unknown reasons, the
formation of the gigohm seal and stabilization of the gigohm seal
during the prolonged experimental perfusion require the presence of
millimolar concentration of either Ca
2þ or Mg
2þ at both sides of the
membrane patch. Thus, 20 mM Ca
2þor Mg
2þwas added in the pipette
and the EGTA solutions, respectively.) A seal resistance of 3–5 GX was
often reached. After being excised, the pipette tip was positioned in
frontof theopeningof a single-walled, three-barrel glasstube(0.7-mm
ID) of the SF-77B perfusion system (Warner Instruments). The
perfusates were gravity fed, and the ﬂow speed at the opening of the
tubing was estimated to be approximately 0.5 cm/s. The speed of
perfusate exchange (from the beginning of the stepping signal to the
activation of channels) is approximately 61 6 14 msec (n ¼ 75). The
excised membranes were held at 50 mV for all the recordings. Signals
were ampliﬁed by an EPC7 Patch Clamp Ampliﬁer (HEKA Instru-
ments). The macroscopic currents were digitized at 1 kHz by a
Digidata1322A digitizer (Axon Instruments) and ﬁltered at 500 Hz by
an in-line eight-pole Bessel ﬁlter (Frequency Devices) unless otherwise
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5 kHz (further ﬁltered at 1 kHz with a Clampﬁt 9 software for
presentation). All statistics are shown as mean 6 the standard
deviation (SD).
The synthetic peptides, aa1–17 (MVLVIEIIRKHLPRVLK-[NH2]),
aa1–17(L3D) (MVDVIEIIRKHLPRVLK-[NH2]), and aa1–6 (MVLVIE-
[NH2]), were from Sigma-Genosys, and aa1–11 (MVLVIEIIRKH-
[NH2]) was from Celtek Peptides. Stock solutions were prepared at
1–30 mM in water, and their actual concentrations were determined
with a NMR using DSS (2,2-dimethyl-2-silapentane-5-sulfonic acid) as
an internal standard. Before usage, the stocks were diluted into the
perfusion solutions and the pH was retitrated to 7.5.
RCK puriﬁcation and
1H-NMR binding analyses. Isolated RCK
domain (M107-A336) for NMR study were puriﬁed from the soluble
fraction of the cell lysate in which the wild-type MthK was expressed
from the pQE70-MthK plasmid (a gift from R. MacKinnon) [9,13]. The
puriﬁed RCK protein, after thrombin cleavage of the C-terminal His-
tag, was dialyzed into 20 mM Tris-HCl (pH 7.5), 150 mM KCl, and 1
mM DTT and concentrated to approximately 200 lM for NMR
analysis.
NMR spectra were recorded using Bruker Avance700 spectrometer
equipped with CryoProbe. Spectra were recorded at 25 8C, with a 4-s
relaxation delay. The initial peptide concentrations were veriﬁed
using 0.1 mM DSS as a concentration standard. Chemical shifts were
calibrated using DSS-Si-(CH3)3 signal as the internal standard at 0.0
ppm. For all peptide titration sets, NMR spectra were recorded for
the following [peptide]:[RCK] ratios: 0:1, 1:5, 1:2, 1:1, and 1:0. Peptide
solutions for titration were prepared using RCK dialysis buffer (20
mM Tris-HCl [pH 7.5], 150 mM KCl, and 1 mM DTT).
RCK puriﬁcation, size-exclusion chromatography, and static light
scattering. Isolated RCK domain (M107-A336) were expressed and
puriﬁed as described previously [11]. The puriﬁed protein, after
thrombin cleavage of the N-terminal 9xHis tag, was N-terminal
sequenced, and its molecular weight (25.7 kDa) was conﬁrmed by
mass spectrum analysis. The protein was dialyzed into 20 Tris-KOH
(pH 9.0), 150 K
þ(Cl
 ), 5 EGTA, and 1 DTT, and concentrated to
approximately 5 mg/ml for injection. The protein was further
dialyzed into 20 Tris-KCl (pH 9.0), 150 KCl, and 1 DTT to remove
EGTA. Concentrated CaCl2 solution was added to the protein sample
to the desired ﬁnal concentration before injection into a Superdex
200 10/300 GL column. In-line static light scattering was performed as
described previously [11].
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